Synthetic Nucleic Acids as Potential Therapeutic Tools for Treatment of Bladder Carcinoma-Reference-Cited by-同舟云学术

Synthetic Nucleic Acids as Potential Therapeutic Tools for Treatment of Bladder Carcinoma

Published:2007-02 Issue:2 Volume:51 Page:315-327
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Fuessel Susanne,Meye Axel,Kraemer Kai,Kunze Doreen,Hakenberg Oliver W.,Wirth Manfred P.

Publisher

Elsevier BV

Subject

Urology

Reference85 articles.

1. The prevalence of cancer. Estimates based on the Connecticut Tumor Registry;Feldman;N Engl J Med,1986

2. A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials;Sylvester;J Urol,2004

3. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis;Huncharek;Anticancer Res,2001

4. A Combined Analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council Randomized Clinical Trials for the Prophylactic Treatment of Stage TaT1 Bladder Cancer

5. Shelley MD, Court JB, Kynaston H, Wilt TJ, Coles B, Mason M. Intravesical bacillus Calmette-Guerin versus mitomycin C for Ta and T1 bladder cancer. Cochrane Database Syst Rev 2003:CD003231.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implementation of Nanoparticles in Cancer Therapy;Pharmaceutical Sciences;2017

2. Implementation of Nanoparticles in Cancer Therapy;Handbook of Research on Nanoscience, Nanotechnology, and Advanced Materials;2014

3. Innovative Tratments of Non Muscle Invasive Bladder Cancer;Urologia Journal;2013-04

4. Knocking down cyclin D1b inhibits breast cancer cell growth and suppresses tumor development in a breast cancer model;Cancer Science;2011-05-31

5. RNAi-based Therapeutics Targeting Survivin and PLK1 for Treatment of Bladder Cancer;Molecular Therapy;2011-05